UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 80 filers reported holding UROGEN PHARMA LTD in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,083 | +25.7% | 648,302 | -7.2% | 0.19% | +16.2% |
Q2 2023 | $7,227 | +12.0% | 698,302 | 0.0% | 0.17% | +16.8% |
Q1 2023 | $6,452 | +4.2% | 698,302 | 0.0% | 0.14% | +3.6% |
Q4 2022 | $6,194 | -99.9% | 698,302 | 0.0% | 0.14% | +5.3% |
Q3 2022 | $5,810,000 | +1.6% | 698,302 | 0.0% | 0.13% | +3.1% |
Q2 2022 | $5,719,000 | -6.0% | 698,302 | 0.0% | 0.13% | +19.8% |
Q1 2022 | $6,082,000 | -8.4% | 698,302 | 0.0% | 0.11% | +65.6% |
Q4 2021 | $6,641,000 | -43.5% | 698,302 | 0.0% | 0.06% | -48.4% |
Q3 2021 | $11,745,000 | +10.1% | 698,302 | 0.0% | 0.12% | +10.7% |
Q2 2021 | $10,663,000 | -21.6% | 698,302 | 0.0% | 0.11% | -18.2% |
Q1 2021 | $13,603,000 | +2.2% | 698,302 | -5.4% | 0.14% | -12.7% |
Q4 2020 | $13,304,000 | -6.6% | 738,302 | 0.0% | 0.16% | -20.7% |
Q3 2020 | $14,242,000 | -26.1% | 738,302 | 0.0% | 0.20% | -36.7% |
Q2 2020 | $19,284,000 | +46.4% | 738,302 | 0.0% | 0.31% | +2.3% |
Q1 2020 | $13,171,000 | -46.5% | 738,302 | 0.0% | 0.31% | -35.6% |
Q4 2019 | $24,637,000 | +33.7% | 738,302 | -4.5% | 0.48% | +24.3% |
Q3 2019 | $18,428,000 | +45.1% | 773,302 | +118.9% | 0.38% | +17.5% |
Q2 2019 | $12,698,000 | -2.7% | 353,302 | 0.0% | 0.32% | +4.2% |
Q1 2019 | $13,051,000 | – | 353,302 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |